FAP is also has been proved that can play a role in antifibrosis therapy, Egger et al. (2017) reported that FAP inhibitor PT100 manifests antifibrosis properties in pulmonary fibrosis mice induced by bleomycin (BLM). Here, FAP is linked to pulmonary fibrosis.